Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.
暂无分享,去创建一个
[1] George A. Truskey,et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies , 2014, Nature Medicine.
[2] Lil Pabon,et al. Engineering Adolescence: Maturation of Human Pluripotent Stem Cell–Derived Cardiomyocytes , 2014, Circulation research.
[3] L. Gepstein,et al. Modeling of Arrhythmogenic Right Ventricular Cardiomyopathy With Human Induced Pluripotent Stem Cells , 2013, Circulation. Cardiovascular genetics.
[4] Simona Casini,et al. Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome , 2013, The EMBO journal.
[5] Teng Hong Tan,et al. Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells. , 2013, International journal of cardiology.
[6] Donald M Bers,et al. Screening Drug-Induced Arrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays , 2013, Circulation.
[7] D. Hedges,et al. Dilated cardiomyopathy: the complexity of a diverse genetic architecture , 2013, Nature Reviews Cardiology.
[8] R. Wanders,et al. Cardiolipin deficiency affects respiratory chain function and organization in an induced pluripotent stem cell model of Barth syndrome. , 2013, Stem cell research.
[9] M. Morad,et al. Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects. , 2013, Cell calcium.
[10] G. Condorelli,et al. Generation of human cardiomyocytes: a differentiation protocol from feeder-free human induced pluripotent stem cells. , 2013, Journal of visualized experiments : JoVE.
[11] Donald M Bers,et al. Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity , 2013, Circulation.
[12] Philip Wong,et al. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy. , 2013, European heart journal.
[13] P. Sham,et al. Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing. , 2013, Human molecular genetics.
[14] K. Morgan,et al. Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes , 2013, European heart journal.
[15] Euan A Ashley,et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. , 2013, Cell stem cell.
[16] E. McNally,et al. Genetic mutations and mechanisms in dilated cardiomyopathy. , 2013, The Journal of clinical investigation.
[17] Gordon Keller,et al. Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics , 2013, The Journal of general physiology.
[18] Sean P. Palecek,et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions , 2012, Nature Protocols.
[19] H. Calkins,et al. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs , 2012, Nature.
[20] S. Schiffmann,et al. Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich’s ataxia , 2012, Disease Models & Mechanisms.
[21] C. Siu,et al. Modeling of lamin A/C mutation premature cardiac aging using patient-specific induced pluripotent stem cells , 2012, Aging.
[22] L. Gepstein,et al. Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells. , 2012, Journal of the American College of Cardiology.
[23] Katriina Aalto-Setälä,et al. Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Reveals Early and Delayed Afterdepolarizations , 2012, PloS one.
[24] Shinsuke Yuasa,et al. Disease characterization using LQTS-specific induced pluripotent stem cells. , 2012, Cardiovascular research.
[25] Christine L Mummery,et al. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. , 2012, Circulation research.
[26] J. Itskovitz‐Eldor,et al. Modeling Catecholaminergic Polymorphic Ventricular Tachycardia using Induced Pluripotent Stem Cell-derived Cardiomyocytes , 2012, Rambam Maimonides medical journal.
[27] Rui Chen,et al. Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy , 2012, Science Translational Medicine.
[28] M. Napierala,et al. Understanding the genetic and molecular pathogenesis of Friedreich’s ataxia through animal and cellular models , 2012, Disease Models & Mechanisms.
[29] Laura Iop,et al. Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia , 2012, EMBO molecular medicine.
[30] E R Behr,et al. Inherited Cardiomyopathies , 2012, BMJ.
[31] G. Keller,et al. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. , 2012, Cell stem cell.
[32] Y. Chien,et al. Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification. , 2011, Human molecular genetics.
[33] Azra Fatima,et al. In vitro Modeling of Ryanodine Receptor 2 Dysfunction Using Human Induced Pluripotent Stem Cells , 2011, Cellular Physiology and Biochemistry.
[34] Katriina Aalto-Setälä,et al. Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture , 2011, Disease Models & Mechanisms.
[35] B. Ravina,et al. Mortality in Friedreich Ataxia , 2011, Journal of the Neurological Sciences.
[36] Lior Gepstein,et al. Modelling the long QT syndrome with induced pluripotent stem cells , 2011, Nature.
[37] Divya Rajamohan,et al. Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation , 2011, European heart journal.
[38] G. Keller,et al. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. , 2011, Cell stem cell.
[39] R. Dolmetsch,et al. Using iPS cells to investigate cardiac phenotypes in patients with Timothy Syndrome , 2011, Nature.
[40] J. Wansapura,et al. Cardiac and Skeletal Muscle Defects in a Mouse Model of Human Barth Syndrome* , 2010, The Journal of Biological Chemistry.
[41] Alexander Meissner,et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.
[42] M. Seyfarth,et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. , 2010, The New England journal of medicine.
[43] H. Dietz. New therapeutic approaches to mendelian disorders. , 2010, The New England journal of medicine.
[44] Lei Yang,et al. Patient-specific induced pluripotent stem cell derived models of LEOPARD syndrome , 2010, Nature.
[45] Ronald A. Li,et al. Absence of transverse tubules contributes to non-uniform Ca(2+) wavefronts in mouse and human embryonic stem cell-derived cardiomyocytes. , 2009, Stem cells and development.
[46] M. Hasegawa,et al. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.
[47] Sean P. Palecek,et al. Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells , 2009, Circulation research.
[48] J. Schiller,et al. Calcium Handling in Human Embryonic Stem Cell‐Derived Cardiomyocytes , 2008, Stem cells.
[49] Eric D. Adler,et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population , 2008, Nature.
[50] H. Calkins,et al. Mechanisms of Disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy , 2008, Nature Clinical Practice Cardiovascular Medicine.
[51] Shulan Tian,et al. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.
[52] M. Ruiters,et al. Pompe disease: current state of treatment modalities and animal models. , 2007, Molecular genetics and metabolism.
[53] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[54] S. Yamanaka,et al. Induction of pluripotent stem cells from fibroblast cultures , 2007, Nature Protocols.
[55] S. Ellard,et al. The laminopathies: a clinical review , 2006, Clinical genetics.
[56] R. Shah,et al. Can pharmacogenetics help rescue drugs withdrawn from the market? , 2006, Pharmacogenomics.
[57] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[58] Michael D. Schneider,et al. Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. , 2006, The Journal of clinical investigation.
[59] Y. Sherer,et al. Arrhythmogenic right ventricular dysplasia: a possible cause of sudden incapacitation. , 2004, Aviation, space, and environmental medicine.
[60] W. Hop,et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. , 2003, Pediatrics.
[61] M. Komajda,et al. Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy , 2003, Circulation.
[62] B. Maron. Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.
[63] E. Maestrini,et al. A novel X-linked gene, G4.5. is responsible for Barth syndrome , 1996, Nature Genetics.
[64] J. Berden,et al. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes , 1983, Journal of the Neurological Sciences.
[65] H. Hers. α-Glucosidase deficiency in generalized glycogen-storage disease (Pompe's disease) , 1963 .